HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Dr. Reddy’s, Nestle India enter into definitive agreement to form joint venture
Apr-25-2024

Dr. Reddy’s Laboratories and Nestle India have entered into a definitive agreement to form a joint venture (JV Company) to bring innovative nutraceutical brands to consumers in India and other agreed territories. The partnership will bring together the well-known global range of nutritional health solutions as well as vitamin, minerals, herbals and supplements of Nestle Health Science (NHSc) with the strong and established commercial strengths of Dr. Reddy’s in India. The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios in categories such as metabolic, hospital nutrition, general wellness , women’s health and child nutrition for consumers across India. 

The JV Company will be headquartered in Hyderabad. The JV Company will leverage the capabilities as well as services of the Nestle Group and Dr. Reddy’s.  Select brands will be licensed by the JV Partners to the JV company. The Nestle Group will license brands such as Nature's Bounty, Osteo Bi-Flex, Ester-C, Resource High Protein, Optifast, Resource Diabetic, Peptamen, Resource Renal and Resource Dialysis. Dr. Reddy’s will license brands such as Rebalanz, Celevida, Antoxid, Kidrich-D3, Becozinc in the nutrition, and OTC segments. The JV Company is expected to become operational in Q2 of FY25.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


  RELATED NEWS >>